These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

778 related articles for article (PubMed ID: 25813447)

  • 1. A Phase II Study of Pazopanib in Patients with Localized Renal Cell Carcinoma to Optimize Preservation of Renal Parenchyma.
    Rini BI; Plimack ER; Takagi T; Elson P; Wood LS; Dreicer R; Gilligan T; Garcia J; Zhang Z; Kaouk J; Krishnamurthi V; Stephenson AJ; Fergany A; Klein EA; Uzzo RG; Chen DY; Campbell SC
    J Urol; 2015 Aug; 194(2):297-303. PubMed ID: 25813447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Functional Outcome of Partial Nephrectomy for Complex R.E.N.A.L. Score Tumors With or Without Neoadjuvant Sunitinib: A Multicenter Analysis.
    McDonald ML; Lane BR; Jimenez J; Lee HJ; Yim K; Bindayi A; Hamilton ZA; Field CA; Bloch AS; Dey S; Noyes S; McKay R; Millard F; Rini BI; Campbell SC; Derweesh IH
    Clin Genitourin Cancer; 2018 Apr; 16(2):e289-e295. PubMed ID: 29113767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [NEOADJUVANT TARGET THERAPY IN A RENAL-CELL CANCER].
    Stakhovskiy EO; Voylenko OA; Stakhovskiy OE; Vitruk YV; Vukalovych PS; Kononenko OA
    Klin Khir; 2015 Dec; (12):41-3. PubMed ID: 27025031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robotic partial nephrectomy after pazopanib treatment in a solitary kidney with segmental vein thrombosis.
    Garisto JD; Dagenais J; Sagalovich D; Bertolo R; Rini B; Kaouk J
    Int Braz J Urol; 2019; 45(4):859. PubMed ID: 30901174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma.
    Thomas AA; Rini BI; Lane BR; Garcia J; Dreicer R; Klein EA; Novick AC; Campbell SC
    J Urol; 2009 Feb; 181(2):518-23; discussion 523. PubMed ID: 19100579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative predictors of surgical approach for partial nephrectomy.
    Raman JD; Smith B; Messer J; Rohner TJ; Harpster LE; Reese CT
    Can J Urol; 2011 Oct; 18(5):5896-902. PubMed ID: 22018152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography characteristics of unresectable primary renal cell carcinoma treated with neoadjuvant sunitinib.
    Salem ME; Shah SN; Elson P; Garcia JA; Wood LS; Medsinge A; Campbell S; Dreicer R; Rini BI
    Clin Genitourin Cancer; 2014 Apr; 12(2):117-23. PubMed ID: 24126239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presurgical sunitinib reduces tumor size and may facilitate partial nephrectomy in patients with renal cell carcinoma.
    Lane BR; Derweesh IH; Kim HL; O'Malley R; Klink J; Ercole CE; Palazzi KL; Thomas AA; Rini BI; Campbell SC
    Urol Oncol; 2015 Mar; 33(3):112.e15-21. PubMed ID: 25532471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of preoperative kidney volume for predicting renal function in renal cell carcinoma patients receiving a radical or partial nephrectomy.
    Jeon HG; Gong IH; Hwang JH; Choi DK; Lee SR; Park DS
    BJU Int; 2012 May; 109(10):1468-73. PubMed ID: 21883863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrometry score is associated with volume loss and functional recovery after partial nephrectomy.
    Simmons MN; Hillyer SP; Lee BH; Fergany AF; Kaouk J; Campbell SC
    J Urol; 2012 Jul; 188(1):39-44. PubMed ID: 22578726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effects of Neoadjuvant Axitinib on Anthropometric Parameters in Patients With Locally Advanced Non-metastatic Renal Cell Carcinoma.
    Chéry L; Borregales LD; Fellman B; Urbauer DL; Garg N; Parker N; Katz MHG; Wood CG; Karam JA
    Urology; 2017 Oct; 108():114-121. PubMed ID: 28705573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal tumour anatomical characteristics and functional outcome after partial nephrectomy.
    Nisen H; Heimonen P; Kenttä L; Visapää H; Nisen J; Taari K
    Scand J Urol; 2015 Jun; 49(3):193-9. PubMed ID: 25385687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year analysis for predicting renal function and contralateral hypertrophy after robot-assisted partial nephrectomy: A three-dimensional segmentation technology study.
    Kim DK; Jang Y; Lee J; Hong H; Kim KH; Shin TY; Jung DC; Choi YD; Rha KH
    Int J Urol; 2015 Dec; 22(12):1105-11. PubMed ID: 26332540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Comparison of Renal Tumor Enucleation Versus Standard Partial Nephrectomy.
    Dong W; Gupta GN; Blackwell RH; Wu J; Suk-Ouichai C; Shah A; Capodice SE; Quek ML; Caraballo Antonio E; Aguilar Palacios D; Remer EM; Li J; Zabell J; Isharwal S; Campbell SC
    Eur Urol Focus; 2017 Oct; 3(4-5):437-443. PubMed ID: 28753814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of inter-observer agreement on feasibility of partial nephrectomy before and after neoadjuvant axitinib for locally advanced renal cell carcinoma (RCC): independent analysis from a phase II trial.
    Karam JA; Devine CE; Fellman BM; Urbauer DL; Abel EJ; Allaf ME; Bex A; Lane BR; Thompson RH; Wood CG
    BJU Int; 2016 Apr; 117(4):629-35. PubMed ID: 26033220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Implications of Renal Tumor Enucleation Relative to Standard Partial Nephrectomy.
    Blackwell RH; Li B; Kozel Z; Zhang Z; Zhao J; Dong W; Capodice SE; Barton G; Shah A; Wetterlin JJ; Quek ML; Campbell SC; Gupta GN
    Urology; 2017 Jan; 99():162-168. PubMed ID: 27614120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Partial nephrectomy after neoadjuvant administration of sunitinib facilitates preservation of a solitary kidney].
    von Klot C; Becker JU; Grünwald V; Peters I; Kuczyk MA; Merseburger AS
    Aktuelle Urol; 2012 Sep; 43(5):337-9. PubMed ID: 22911381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
    Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
    J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing renal function preservation after laparoscopic radio frequency ablation assisted tumor enucleation and laparoscopic partial nephrectomy for clinical T1a renal tumor: using a 3D parenchyma measurement system.
    Zhu L; Wu G; Huang J; Wang J; Zhang R; Kong W; Xue W; Huang Y; Chen Y; Zhang J
    J Cancer Res Clin Oncol; 2017 May; 143(5):905-912. PubMed ID: 28188362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
    La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
    J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.